Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN21334657
ISRCTN21334657
Completed
Not Applicable

Early treatment of patients with undifferentiated arthritis (UA) with Methotrexate (MTX)

eiden University Medical Center (LUMC) (Netherlands)0 sites110 target enrollmentSeptember 12, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsndifferentiated arthritis, probable rheumatoid arthritis according to ACR-1958 criteriaMusculoskeletal DiseasesOther arthrosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ndifferentiated arthritis, probable rheumatoid arthritis according to ACR-1958 criteria
Sponsor
eiden University Medical Center (LUMC) (Netherlands)
Enrollment
110
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 12, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
eiden University Medical Center (LUMC) (Netherlands)

Eligibility Criteria

Inclusion Criteria

  • •1\. Diagnosis probable RA according to the ACR\-1958 criteria
  • •2\. Aged 18 years or older
  • •3\. Less than 2 years of complaints
  • •4\. No DMARD use in the past (except Prednisone, maximal 3 months)
  • •5\. Signed informed consent

Exclusion Criteria

  • •1\. Diagnosis RA according to the ACR\-1987 criteria
  • •2\. Kidney disorder: creatinine \>150umol/l or estimated clearance \< 75
  • •3\. Liver function disorder: ASAT, ALAT \> 3x normal values
  • •4\. Alcoholism
  • •5\. Bone marrow insufficiency
  • •6\. Pregnant or pregnancy wish during study or 3 months thereafter
  • •7\. No adequate method of birth control

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
sing two drugs in combination at the start of drug treatment for type 2 diabetes vs using a single drug
ISRCTN26805203Pakistan Institute of Medical Sciences285
Recruiting
Not Applicable
Evaluation and treatment of patients with unilateral vocal fold paralysisPatients with unilateral vocal fold paralysis
JPRN-UMIN000002538Kumamoto University100
Active, not recruiting
Phase 1
Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaMedDRA version: 20.0Level: LLTClassification code 10000845Term: Acute lymphoblastic leukemiaSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10003939Term: B-lymphoblastic lymphoma (Kiel Classification)System Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2011-003430-13-IEChildren's Oncology Group9,483
Recruiting
Phase 1
CAR-T-cell treatment for untreated high risk MANtle Cell LymphomaMantle Cell Lymphoma (MCL)MedDRA version: 21.0Level: PTClassification code: 10026805Term: Mantle cell lymphoma stage IV Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10026803Term: Mantle cell lymphoma stage II Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10026804Term: Mantle cell lymphoma stage III Class: 100000004864Therapeutic area: Diseases [C] - Neoplasms [C04]
CTIS2022-502405-15-01Klinikum Der Universitat Munchen AöR91
Not yet recruiting
Not Applicable
Should a patient with a clinically suspected scaphoid fracture be treated with a cast?clinical suspected scaphoid fracture. Klinische verdenking scaphoid fractuur
NL-OMON20183Erasmus MC180